Literature DB >> 33442846

The Role of Afamin and Other Trace Elements in the Prediction of GDM: a Tertiary Center Experience.

Hasan Eroğlu1, Gökçen Örgül2, Nazan Vanlı Tonyalı2, Derya Biriken3, Naci Polat4, Aykan Yücel2, Nuray Yazihan4, Dilek Şahin2.   

Abstract

The objective of this study was to evaluate the utility of first trimester maternal serum afamin levels together with vitamin E and various elements (zinc, copper, selenium, and magnesium) for the prediction of gestational diabetes mellitus (GDM). All pregnant women between 11th and 14th weeks of gestation admitted for combined test were asked to participate in the study. A total of 797 women gave permission to participate in the study between January and September 2019. Serum was obtained by centrifugation and samples were frozen and kept at - 80 °C. For final analysis, forty-three GDM patients and forty-four healthy controls were selected. Levels of afamin, vitamin E, zinc, copper, selenium, and magnesium were compared between groups. The mean levels of afamin were found to be higher in women with GDM without statistical significance (63.69 ± 82.33 vs 44.25 ± 32.25 mg/L, p = 0.149). Vitamin E levels were found to be higher in women with GDM compared to controls without any statistical significance (5.04 ± 5.33 vs 4.47 ± 3.83 μg/mL, p = 0.568). While first trimester copper concentrations were higher among diabetic women (187.26 ± 34.78 vs 175.17 ± 30.40 μg/L, p = 0.088), this was not statistically significant. The other element levels (zinc, selenium, and magnesium) were found to be similar between the two groups (p = 0.624, p = 0.088, p = 0.254, p = 0.872, respectively). The results of our study demonstrated that mean levels of afamin, vitamin E, and copper were higher in women with GDM compared to controls. Additionally, first trimester maternal zinc, selenium, and magnesium levels were similar between diabetic and healthy pregnant women. However, more studies are needed to clarify the relationship between blood trace concentrations and GDM.

Entities:  

Keywords:  Afamin; First trimester; Gestational diabetes mellitus; Pregnancy

Year:  2021        PMID: 33442846     DOI: 10.1007/s12011-020-02559-0

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  7 in total

1.  Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels.

Authors:  Hatice Kansu-Celik; A Seval Ozgu-Erdinc; Burcu Kisa; Rahime Bedir Findik; Canan Yilmaz; Yasemin Tasci
Journal:  Arch Endocrinol Metab       Date:  2019-04-25       Impact factor: 2.309

2.  Association of maternal serum copper during early pregnancy with the risk of spontaneous preterm birth: A nested case-control study in China.

Authors:  Yongxiu Hao; Yiming Pang; Huina Yan; Yali Zhang; Jufen Liu; Lei Jin; Lailai Yan; Da Chen; Ligang Hu; Qian Liu; Yanan Qin; Bin Wang; Zhiwen Li; Rongwei Ye; Le Zhang; Aiguo Ren
Journal:  Environ Int       Date:  2018-11-22       Impact factor: 9.621

3.  Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications.

Authors:  L Martinoli; M Di Felice; G Seghieri; M Ciuti; L A De Giorgio; A Fazzini; R Gori; R Anichini; F Franconi
Journal:  Int J Vitam Nutr Res       Date:  1993       Impact factor: 1.784

4.  First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study.

Authors:  Paula J Correa; Pia Venegas; Yasna Palmeiro; Daniela Albers; Gregory Rice; Jaime Roa; Jorge Cortez; Max Monckeberg; Manuel Schepeler; Eduardo Osorio; Sebastian E Illanes
Journal:  J Perinat Med       Date:  2019-02-25       Impact factor: 1.901

5.  The vitamin E-binding protein afamin increases in maternal serum during pregnancy.

Authors:  Michael Hubalek; Hannes Buchner; Manfred G Mörtl; Dietmar Schlembach; Berthold Huppertz; Branka Firulovic; Wolfgang Köhler; Erich Hafner; Benjamin Dieplinger; Ludwig Wildt; Hans Dieplinger
Journal:  Clin Chim Acta       Date:  2014-04-24       Impact factor: 3.786

6.  Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study.

Authors:  Angela Köninger; Annette Mathan; Pawel Mach; Mirjam Frank; Boerge Schmidt; Ekkehard Schleussner; Rainer Kimmig; Alexandra Gellhaus; Hans Dieplinger
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

7.  First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis.

Authors:  Brittney M Donovan; Nichole L Nidey; Elizabeth A Jasper; Jennifer G Robinson; Wei Bao; Audrey F Saftlas; Kelli K Ryckman
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total
  4 in total

1.  Putrescine as a Novel Biomarker of Maternal Serum in First Trimester for the Prediction of Gestational Diabetes Mellitus: A Nested Case-Control Study.

Authors:  Cheng Liu; Yuanyuan Wang; Wei Zheng; Jia Wang; Ya Zhang; Wei Song; Aili Wang; Xu Ma; Guanghui Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

Review 2.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0.

Authors:  Monika Ruszała; Aleksandra Pilszyk; Magdalena Niebrzydowska; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

Review 3.  Association of Selenium Levels with Gestational Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis.

Authors:  Hamdan Z Hamdan; Sumaia Zaki Hamdan; Ishag Adam
Journal:  Nutrients       Date:  2022-09-23       Impact factor: 6.706

4.  Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.

Authors:  Imre Juhász; Szilvia Ujfalusi; Ildikó Seres; Hajnalka Lőrincz; Viktória Evelin Varga; György Paragh; Sándor Somodi; Mariann Harangi; György Paragh
Journal:  Biomolecules       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.